Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
1500 participants
INTERVENTIONAL
2021-11-22
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-invasive Prenatal Diagnostic Validation Study
NCT01574781
Cell- Based Noninvasive Prenatal Testing (NIPT): Single Cell Prenatal Diagnosis (SCPD)
NCT05076734
Validate Non-invasive Prenatal Tests for the Detection of Chromosomal Abnormalities
NCT05618431
Noninvasive Prenatal Diagnosis: Using Fetal Cells From Maternal Blood
NCT00064597
Development of a Prenatal Test for Fetal Aneuploidy Detection
NCT01451671
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Blood samples from pregnant women
Samples of peripheral blood collected from pregnant women undergoing CVS or genetic amniocentesis
Cell-based non-invasive prenatal testing
Blood sampling
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cell-based non-invasive prenatal testing
Blood sampling
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women who have already been selected by their treating physician to undergo an invasive fetal diagnostic procedure
* Participant is at least 18 years old and can provide informed consent
Exclusion Criteria
* Prenatal diagnosis of clinical Chorioamnionitis
* Intake of drugs or exposure to teratogenic agents
* Infections that carry a risk of vertical transmission
* Known maternal viral diseases: HIV and HCV, HBV
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Menarini Biomarkers Singapore
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondazione IRCCS Ca' Granda-Policlinico di Milano Ospedale Maggiore
Milan, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Enrico Ferrazzi, Prof.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MBS21-CBNIPD-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.